[go: up one dir, main page]

AU2000233235A1 - Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase - Google Patents

Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Info

Publication number
AU2000233235A1
AU2000233235A1 AU2000233235A AU3323500A AU2000233235A1 AU 2000233235 A1 AU2000233235 A1 AU 2000233235A1 AU 2000233235 A AU2000233235 A AU 2000233235A AU 3323500 A AU3323500 A AU 3323500A AU 2000233235 A1 AU2000233235 A1 AU 2000233235A1
Authority
AU
Australia
Prior art keywords
antagonists
treatment
aromatase
interleukin
high levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000233235A
Other languages
English (en)
Inventor
Michael John Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2000233235A1 publication Critical patent/AU2000233235A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AU2000233235A 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase Abandoned AU2000233235A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (1)

Publication Number Publication Date
AU2000233235A1 true AU2000233235A1 (en) 2001-09-17

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000233235A Abandoned AU2000233235A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Country Status (17)

Country Link
US (1) US7160860B2 (xx)
EP (1) EP1261367B1 (xx)
JP (1) JP2003525906A (xx)
KR (1) KR100694005B1 (xx)
AT (1) ATE295735T1 (xx)
AU (1) AU2000233235A1 (xx)
CA (1) CA2400711A1 (xx)
CZ (1) CZ20022760A3 (xx)
DE (1) DE60020269T2 (xx)
DK (1) DK1261367T3 (xx)
ES (1) ES2241583T3 (xx)
HU (1) HUP0300117A3 (xx)
MX (1) MXPA02008697A (xx)
PL (1) PL356846A1 (xx)
PT (1) PT1261367E (xx)
SK (1) SK12412002A3 (xx)
WO (1) WO2001066131A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
BRPI0906516A2 (pt) 2008-01-17 2019-09-24 Synthes Gmbh implante intervertebral expansível e método associado para a fabricação do mesmo.
JP5441997B2 (ja) 2008-04-05 2014-03-12 ジンテス ゲゼルシャフト ミット ベシュレンクテル ハフツング 拡張可能な椎骨間インプラント
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9763678B2 (en) 2010-06-24 2017-09-19 DePuy Synthes Products, Inc. Multi-segment lateral cage adapted to flex substantially in the coronal plane
AU2011271465B2 (en) 2010-06-29 2015-03-19 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8940052B2 (en) 2012-07-26 2015-01-27 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
EP4233801A3 (en) 2016-06-28 2023-09-06 Eit Emerging Implant Technologies GmbH Expandable, angularly adjustable intervertebral cages
AU2017286831B2 (en) 2016-06-28 2022-06-09 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable articulating intervertebral cages
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
EP1261367A1 (en) 2002-12-04
PL356846A1 (en) 2004-07-12
DK1261367T3 (da) 2005-09-12
PT1261367E (pt) 2005-09-30
US7160860B2 (en) 2007-01-09
KR20020079984A (ko) 2002-10-21
KR100694005B1 (ko) 2007-03-12
HUP0300117A2 (hu) 2003-04-28
ES2241583T3 (es) 2005-11-01
WO2001066131A1 (en) 2001-09-13
DE60020269D1 (de) 2005-06-23
SK12412002A3 (sk) 2002-12-03
US20050090443A1 (en) 2005-04-28
EP1261367B1 (en) 2005-05-18
ATE295735T1 (de) 2005-06-15
DE60020269T2 (de) 2006-01-19
HUP0300117A3 (en) 2005-09-28
CZ20022760A3 (cs) 2003-03-12
MXPA02008697A (es) 2003-04-14
JP2003525906A (ja) 2003-09-02
CA2400711A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
BG108499A (en) A novel engineered superantigen for human therapy
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
MY169308A (en) Treatment of tnf? related disorders
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
MY140539A (en) 1-amino 1h-imidazoquinolines
GB0111186D0 (en) Novel compounds
MXPA02011288A (es) Tioacetamidas substituidas.
MXPA04003796A (es) Tioacetamidas sustituidas.
AU2002358390A1 (en) Novel compounds
HK1040983A1 (en) Quinones for treatment of diseases.
AU2001234273A1 (en) Thiazolopyrimidines and their use as modulators of chemokine receptor activity
TW200508233A (en) Chk-1 inhibitors
WO2003105753A3 (en) METHODS AND COMPOSITIONS FOR GRAFTING FUNCTIONAL LOOPS INTO A PROTEIN
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
AU2002251788A1 (en) Novel compounds and uses thereof
RS20060023A (xx) Upotreba rastvorljivih cd164 u zapaljenskim i/ili autoimunim poremećajima
DE60320422D1 (de) Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen